{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:55:15Z","timestamp":1793904915724,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009321","name":"icare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021840","name":"icare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022217","name":"Flinders Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.lungcan.2024.107542","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:30:02Z","timestamp":1711643402000},"page":"107542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Establishing mesothelioma patient-derived organoid models from malignant pleural effusions"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8311-8984","authenticated-orcid":false,"given":"Ashleigh J.","family":"Hocking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Farrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lungcan.2024.107542_b0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"issue":"14","key":"10.1016\/j.lungcan.2024.107542_b0010","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"10272","key":"10.1016\/j.lungcan.2024.107542_b0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lungcan.2024.107542_b0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107542_b0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1078-0432.CCR-16-0844","article-title":"Patient-derived Xenograft establishment from human malignant pleural mesothelioma","volume":"23","author":"Wu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2024.107542_b0030","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41416-020-0993-5","article-title":"Current concepts in tumour-derived organoids","volume":"123","author":"Porter","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"6378","key":"10.1016\/j.lungcan.2024.107542_b0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"9","key":"10.1016\/j.lungcan.2024.107542_b0040","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lungcan.2024.107542_b0050","first-page":"130","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"npj Prec. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-023-02683-4","article-title":"Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study","volume":"42","author":"Jensen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107542_b0060","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0065","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41467-021-22676-1","article-title":"Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0070","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","article-title":"In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening","volume":"8","author":"Mazzocchi","year":"2018","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.lungcan.2024.107542_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153758","article-title":"Organoids as a model for precision medicine in malignant pleural mesothelioma: where are we today?","volume":"14","author":"Gao","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107542_b0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/OP.21.00426","article-title":"Management of advanced pleural mesothelioma-at the crossroads","volume":"18","author":"Nowak","year":"2022","journal-title":"JCO Oncol Pract."},{"key":"10.1016\/j.lungcan.2024.107542_b0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jprot.2018.09.018","article-title":"Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma","volume":"192","author":"White","year":"2019","journal-title":"J. Proteomics"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107542_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111606","article-title":"Diagnostic and prognostic utility of the extracellular vesicles subpopulations present in pleural effusion","volume":"11","author":"Javadi","year":"2021","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107542_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/genes13112159","article-title":"Extracellular vesicle MicroRNA in malignant pleural effusion","volume":"13","author":"Shojaee","year":"2022","journal-title":"Genes (Basel)"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107542_b0100","article-title":"Diving into the pleural fluid: liquid biopsy for metastatic malignant pleural effusions","volume":"13","author":"Sorolla","year":"2021","journal-title":"Cancers [Internet]."},{"issue":"140","key":"10.1016\/j.lungcan.2024.107542_b0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur. Respir. Rev."},{"issue":"9329","key":"10.1016\/j.lungcan.2024.107542_b0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2024.107542_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.658395","article-title":"Pleural fluid has pro-growth biological properties which enable cancer cell proliferation","volume":"11","author":"Asciak","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0120","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107542_b0125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)."},{"issue":"W1","key":"10.1016\/j.lungcan.2024.107542_b0130","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lungcan.2024.107542_b0135","unstructured":"Oliveros JC. Venny. An interactive tool for comparing lists with Venn's diagrams 2007-2015 [Available from: https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html."},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2024.107542_b0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107542_b0145","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T Cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.lungcan.2024.107542_b0150","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107542_b0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2\u201340, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13073-022-01060-8","article-title":"Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma","volume":"14","author":"Creaney","year":"2022","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13073-021-00931-w","article-title":"Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma","volume":"13","author":"Meiller","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.lungcan.2024.107542_b0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lungcan.2018.03.009","article-title":"Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations","volume":"119","author":"Sneddon","year":"2018","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107542_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107542_b0185","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/bjs.11206","article-title":"Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy","volume":"106","author":"Ubink","year":"2019","journal-title":"Br. J. Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107542_b0190","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11626-021-00563-9","article-title":"Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform","volume":"57","author":"Pan","year":"2021","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107542_b0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107542_b0200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/dc.25129","article-title":"The cytological features of effusions with mesothelioma in situ: A report of 9 cases","volume":"51","author":"Michael","year":"2023","journal-title":"Diagn. Cytopathol."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107542_b0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1165\/rcmb.2004-0355OC","article-title":"A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance","volume":"33","author":"Kim","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12307-010-0048-1","article-title":"Kinetics of host cell recruitment during dissemination of diffuse malignant peritoneal mesothelioma","volume":"4","author":"Miselis","year":"2010","journal-title":"Cancer Microenviron."},{"issue":"10","key":"10.1016\/j.lungcan.2024.107542_b0215","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Douglas","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lungcan.2024.107542_b0220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.semcancer.2018.06.005","article-title":"Patient-derived tumor organoids for prediction of cancer treatment response","volume":"53","author":"Nagle","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107542_b0230","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.stemcr.2017.02.005","article-title":"Stem cell factor-based identification and functional properties of in vitro-selected subpopulations of malignant mesothelioma cells","volume":"8","author":"Blum","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107542_b0235","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41467-021-21798-w","article-title":"Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107542_b0240","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41571-022-00649-7","article-title":"Immunotherapy approaches for malignant pleural mesothelioma","volume":"19","author":"Fennell","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T22:33:20Z","timestamp":1715639600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"alternative-id":["S0169500224000758"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107542","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing mesothelioma patient-derived organoid models from malignant pleural effusions","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107542"}}